| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.008 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.009 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.009 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |